Treatment Selection Strategies in Advanced...
2
WCLC 2016 - Vienna, Austria IASLC 17th World Conference on Lung Cancer Treatment Selection Strategies in Advanced NSCLC Sunday, 4 December 2016 • 17:15 – 18:45 Hall C1, Vienna Messe Co-Chairs Tony Mok, Hong Kong Giorgio Scagliotti, Italy Faculty Luis Paz-Ares, Spain Maurice Pérol, France Joachim Aerts, The Netherlands
Transcript of Treatment Selection Strategies in Advanced...
-
WCLC 2016 - Vienna, Austria IASLC 17th World Conference on Lung Cancer
Treatment Selection Strategies in Advanced NSCLC
Sunday, 4 December 2016 • 17:15 – 18:45Hall C1, Vienna Messe
Co-Chairs Tony Mok, Hong Kong Giorgio Scagliotti, Italy
Faculty Luis Paz-Ares, Spain Maurice Pérol, France Joachim Aerts, The Netherlands
-
WCLC 2016 - Vienna, Austria IASLC 17th World Conference on Lung Cancer
Treatment Selection Strategies in Advanced NSCLC
ATON
C00287
Agenda17:15 Welcome & Introduction
Co-Chairs
17:20 Orchestral Manoeuvres of the Immune Checkpoint Inhibitors: Targeted or Untargeted Agents? Joachim Aerts, The Netherlands
17:45 Variation on a Theme: Angiogenesis Inhibition Across Treatment Lines Maurice Pérol, France
18:05 Keys to Biomarker Driven Choices in 2nd Line Luis Paz-Ares, Spain
18:25 Is the Score Yet Written? Giorgio Scagliotti, Italy
18:30 Discussion: the Unfinished Symphony Tony Mok, Hong Kong
18:45 Symposium Closes
This presentation was approved by the IASLC 17th World Conference on Lung Cancer Program Committee as an independent activity held in conjunction with the IASLC 17th World Conference on Lung Cancer. This presentation is not sponsored or endorsed by IASLC.
16:45 – 17:15 Light Refreshments Served
